RA Capital Healthcare Fund LP
10% Owner; Director; Director, 10% Owner · 67 filings · Latest: Oct 5, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Freenome, Inc.
Hemab Therapeutics Holdings, Inc.
Inhibikase Therapeutics, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences, Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VOR | RA Capital Healthcare Fund LP | 10% Owner | Oct 2, 2026 | Option Exercise | $12.80 | 500 | $6.4K | 500 | |
CLYM | RA Capital Healthcare Fund LP | Director, 10% Owner | Sep 28, 2026 | Option Exercise | $2.79 | 70,000 | $195.1K | 70,000 | |
SION | RA Capital Healthcare Fund LP | Director | Sep 17, 2026 | Sale | $6.33 | 3,448,811 | $21.8M | 3,448,812 | |
SION | RA Capital Healthcare Fund, L.P. | — | Sep 17, 2026 | Proposed Sale | $6.33 | 3,448,811 | $21.8M | — | |
VOR | RA Capital Healthcare Fund LP | 10% Owner | Aug 24, 2026 | Option Exercise | $3.74 | 1,500 | $5.6K | 1,500 | |
SEPN | RA Capital Healthcare Fund LP | Director, 10% Owner | Aug 12, 2026 | Sale | $42.50 | 1,493,000 | $63.5M | 725,443 | |
SEPN | RA Capital Healthcare Fund LP | — | Aug 12, 2026 | Proposed Sale | $48.19 | 746,500 | $36.0M | — | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 31, 2026 | Purchase | $9.93 | 24,944 | $247.7K | 17,329,570 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 29, 2026 | Purchase | $9.99 | 20,824 | $208.0K | 17,304,626 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 24, 2026 | Purchase | $9.99 | 41,319 | $412.8K | 17,283,802 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 23, 2026 | Purchase | $9.96 | 59,880 | $596.4K | 17,242,483 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 22, 2026 | Purchase | $9.93 | 84,124 | $835.4K | 17,182,603 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 21, 2026 | Purchase | $9.55 | 120,582 | $1.2M | 17,098,479 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 13, 2026 | Purchase | $8.94 | 6,522 | $58.3K | 16,817,543 | |
PBLS | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 22, 2026 | Purchase | $29.77 | 47,250 | $1.4M | 26,529,686 | |
PBLS | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 21, 2026 | Purchase | $29.25 | 65,923 | $1.9M | 26,482,436 | |
PBLS | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 20, 2026 | Purchase | $27.28 | 131,420 | $3.6M | 26,416,513 | |
VOR | RA Capital Healthcare Fund LP | 10% Owner | Jul 16, 2026 | Sale | $19.75 | 213 | $4.2K | 4,501,882 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 17, 2026 | Purchase | $8.95 | 7,882 | $70.5K | 16,977,927 | |
ARTV | RA Capital Healthcare Fund LP | Director, 10% Owner | Jul 16, 2026 | Purchase | $8.93 | 152,472 | $1.4M | 16,970,045 |
Page 1 of 5
Next →